Nasopharyngeal carcinoma (NPC) is the fourth most frequent tumor after skin, breast, and cervical cancer in Indonesia (Adham et al., 2012). The majority of NPC patients receive a late diagnosis since the disease's early symptoms are non-specific. Therefore, a biomarker is needed to detect NPC early. Interestingly, NPC onset and progression are highly correlated with Epstein-Bar Virus (EBV) …